Regular late-life exercise has a beneficial impact on DNA damage and telomere dysfunction

FHS
April 7, 2024
8:20 am

Regular aerobic exercise later in life prevents genomic instability characterized by DNA damage and telomere dysfunction, according to a study from the Department of Internal Medicine at the University of Utah.

Eli Lilly reports tirzepatide MASH success during Q4 earnings

The blockbuster weight loss and diabetes drug sold by Eli Lilly also appears to improve fatty liver disease, according to early clinical trial data the

February 6, 2024

AD/PD 2024: Eli Lilly’s donanemab hit with FDA delay – Pharmaceutical Technology

Share this article The approval date for Eli Lilly’s donanemab has been pushed from the previously expected time in 1Q 2024 to a date as

March 11, 2024

Androgen clock reveals how hormones shape aging and health

Scientists unveil the androgen clock, a precise epigenetic tool to measure long-term androgen exposure and its role in aging and health.

January 16, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.